- Home
- EKSO
as 11-21-2025 11:12am EST
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | SAN RAFAEL |
| Market Cap: | 7.7M | IPO Year: | N/A |
| Target Price: | $7.75 | AVG Volume (30 days): | 51.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.24 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.73 - $14.97 | Next Earning Date: | 10-28-2025 |
| Revenue: | $14,749,000 | Revenue Growth: | -16.59% |
| Revenue Growth (this year): | -5.49% | Revenue Growth (next year): | 49.96% |
Stock Insider Trading Activity of Ekso Bionics Holdings Inc. (EKSO)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Wong Jerome | EKSO | Chief Financial Officer | Nov 10 '25 | Sell | $4.80 | 11,288 | $54,182.40 | 26,009 | |
| Jones Jason C | EKSO | Chief Operating Officer | Nov 10 '25 | Sell | $4.80 | 9,723 | $46,670.40 | 27,211 | |
| Davis Scott G. | EKSO | CEO | Nov 10 '25 | Sell | $4.80 | 23,315 | $111,912.00 | 78,777 |
Latest Ekso Bionics Holdings Inc. News
EKSO Breaking Stock News: Dive into EKSO Ticker-Specific Updates for Smart Investing
Zacks
a day ago
Ekso Bionics (EKSO) Upgraded to Buy: Here's Why
GlobeNewswire
24 days ago
Ekso Bionics Announces $3.7 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules
Associated Press Finance
25 days ago
Ekso Bionics: Q3 Earnings Snapshot
GlobeNewswire
25 days ago
Ekso Bionics Reports Third Quarter 2025 Financial Results
GlobeNewswire
5 months ago
Ekso Bionics’ Acceptance into NVIDIA Connect Program Bears Early Fruit
GlobeNewswire
6 months ago
Ekso Bionics Announces New Effective Date of Reverse Stock Split
GlobeNewswire
6 months ago
Ekso Bionics Announces Reverse Stock Split
MT Newswires
6 months ago
Ekso Bionics Joins Nvidia Connect Program; Shares Up Pre-Bell
Compare EKSO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EKSO Ekso Bionics Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.